XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.73

-0.2%

11:31 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (16966)	7/1/2004 10:23:04 PM
From: Robert K.	Read Replies (1) of 17367

I have believed for some time now that anti-cd40 will most likely be the first cancer collab to emerge. Having ing-1 in the mix would make a lotta sense but we need a chiron buy-in on that. Regarding BPI, i doubt Dr G will give up as evidenced by the dallas cpb connection. I wonder if any bpi-21 might get heroicly diverted? I also wonder if "probes" have to be announced or if they could be run without fanfare. Would that be a ass-kicker. Also the ever possible but unlikely submission that never was. Re-submit is a misnomer. I would love to see the fda have the balls to turn down bpi-21 after a advisory public forum.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next